Multiple Organ Failure: Clinical Trials

5 trials for Multiple Organ Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 not yet recruiting, 1 unknown. 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 2, Completed 1, Not yet recruiting 1, Unknown 1
Phase 24Completed 1, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Multiple Organ Failure: new trials by email Literature Review of Multiple Organ Failure trials Research Report on Multiple Organ Failure

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial
Point-of-care large language model decision support (ChatGPT-5) - Critical Illness, Sepsis
Phase 1 / Phase 2Not yet recruitingMetroWest Artificial Intelligence Research Workgroup10002026-01-012025-12-18
Clinical Use of Stem Cells for the Treatment of Covid-19
MSC Treatment, Saline Control - Covid19, Pneumonia
Phase 1 / Phase 2CompletedSBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi302020-04-012021-05-25
The Val-CARD Trial
Sodium Valproate - Cardiac Valve Disease, Coronary Artery Disease
Phase 1 / Phase 2TerminatedUniversity of Leicester452018-11-062026-08-17
Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Menstrual blood stem cells - Acute Lung Injury, Acute Respiratory Distress Syndrome (ARDS)
Phase 1 / Phase 2UnknownS-Evans Biosciences Co., Ltd.202014-03-012014-03-24
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
IgM-enriched Intravenous Immunoglobulins, Human Albumin - Polyneuropathies
Phase 1TerminatedMedical University of Vienna382004-12-012013-06-04

Narrower conditions

Critical Illness (2)  ·  Sepsis (2)  ·  Acute Kidney Injury (1)  ·  Acute Lung Injury (1)  ·  COVID-19 (1)  ·  Confusion (1)  ·  Coronary Artery Disease (1)  ·  Coronavirus Infections (1)  ·  Heart Valve Diseases (1)  ·  Pneumonia (1)  ·  Polyneuropathies (1)  ·  Respiratory Distress Syndrome (1)  ·  Shock (1)

Broader conditions

Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Shock (4)  ·  Infections (3)  ·  Disease Attributes (2)  ·  Inflammation (2)  ·  Lung Diseases (2)  ·  Nervous System Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Coronaviridae Infections (1)

Interventions

Immunoglobulins, Intravenous (1)  ·  Serum Albumin, Human (1)  ·  Valproic Acid (1)

Sponsors

Medical University of Vienna (1)  ·  MetroWest Artificial Intelligence Research Workgroup (1)  ·  S-Evans Biosciences Co., Ltd. (1)  ·  SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi (1)  ·  University of Leicester (1)

Countries

Austria (1)  ·  China (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Charlie Xiang, Doctor (1)  ·  Christian Madl, MD (1)  ·  Erdal Karaoz, Prof.Dr. (1)  ·  Eric Silverman, M.D. (1)  ·  Gavin Murphy, MD (1)  ·  Gokhan T Adas, Prof.Dr. (1)  ·  Marius Roman, MD (1)

Results publications

PMID 24088271

NIH funding

2018 (1)